Condition: ALK-positive NSCLC · ALK-Positive Lung Cancer · ALK-positive Non-small Cell Lung Cancer · Sponsor: TRIANA Biomedicines, Inc.
The goal of this clinical trial is to learn about the safety and recommended dose of TRI-611 when administered to adults with ALK-positive non-small cell lung cancer (NSCLC). The trial will also evaluate the antitumor activity of TRI-611 in adults with ALK-positive NSCLC. The study will be conducted in two parts. The first part will examine different doses of TRI-611. The second part will look at how well TRI-611 works on ALK-positive NSCLC when administered to three groups of participants that differ based on what type of prior therapy they have received. In this study participants will: * Take TRI-611 on a continued basis, provided it is well-tolerated, for as long as their disease is not progressing * Visit the clinic approximately seven times in the first 3 months and then just once at the start of each 28-day cycle thereafter * Keep a diary of each time they take the study medication
This description comes directly from the study's public registry record.
TRIANA Clinical Trials · medical@trianabio.com
Always discuss trial participation with your own doctor first.
| UCSF | San Francisco, California, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Dana Farber Cancer Center | Boston, Massachusetts, United States | Recruiting |
| Washington University Medical Center | St Louis, Missouri, United States | Recruiting |
| Memorial Sloan-Kettering Cancer Center | New York, New York, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Taylor Cancer Research Center | Maumee, Ohio, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| Oncology Consultants Research (P1 Trials) | Houston, Texas, United States | Recruiting |
| START Mountain Region | West Valley City, Utah, United States | Recruiting |
| NEXT Virginia | Fairfax, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07491497